Nutrition and Cancer · 2015 · 55 citations · 105 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyNanoparticle Drug DeliveryChemotherapy ResistanceDrug ResistanceEfflux-mediated ResistanceMultidrug ResistanceNanomaterials For Drug DeliveryTherapeutic ResistanceAbc TransportersDrug Efflux MechanismsDrug Efflux PumpsNanoparticle DeliveryNanoparticle Drug Delivery SystemsOvercoming Multidrug ResistanceTherapeutic Resistance MechanismsTransporters
Multidrug resistance (MDR) is a condition that makes cells simultaneously unresponsive to different drugs, unrelated to their chemical structure and mechanism of action. MDR caused by the presence and overexpression of ABC transporters makes obstacles in cancer treatment and lower the effectiveness of chemotherapy. Natural products are investigated by many researchers as MDR modulators for their low toxicity and potent, selective behavior. When coadministered, MDR modulators compete with cytotoxic agents for binding to the active site of the membrane transporters and reduce drug efflux. Natural product-based drugs are important in struggling against drug resistance during cancer therapy. This review is focused on the potential mechanisms against drug resistance, the development of inhibitors for ABC drug transporters, natural product modulators, and nanoparticle drug delivery.
105
Identification and characterization of a new member of the TNF family that induces apoptosis
Steven R. Wiley, Ken Schooley, Pamela J. Smolak et al. · Immunity · 1995 · 2.9K citations · Full text
Anticancer potential of curcumin: preclinical and clinical studies.
Bharat B. Aggarwal, Anushree Kumar, Alok C. Bharti · PubMed · 2003 · 2.6K citations
Medicine, Oncology, Pharmacology +15
Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations
Medicine, Oncology, Pharmacology +10